BioMerieux Cash on Hand 2017-2024 | BMXMF

BioMerieux cash on hand from 2017 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • BioMerieux cash on hand for the quarter ending December 31, 2024 was $0.487B, a 12.75% decline year-over-year.
  • BioMerieux cash on hand for 2023 was $0.381B, a 34.49% decline from 2022.
  • BioMerieux cash on hand for 2022 was $0.582B, a 38.75% decline from 2021.
  • BioMerieux cash on hand for 2021 was $0.951B, a 113.82% increase from 2020.
BioMerieux Annual Cash on Hand
(Millions of US $)
2023 $381
2022 $582
2021 $951
2020 $445
2019 $308
2018 $331
2017 $353
2016 $198
2015 $0
BioMerieux Quarterly Cash on Hand
(Millions of US $)
2024-12-31 $487
2023-12-31 $381
2023-06-30 $461
2022-12-31 $582
2022-06-30 $558
2021-12-31 $951
2021-06-30 $594
2020-12-31 $445
2019-12-31 $308
2019-06-30 $278
2018-12-31 $331
2018-06-30 $232
2017-12-31 $353
2017-06-30 $200
2016-12-31 $198
Sector Industry Market Cap Revenue
Medical Medical Services $15.594B $4.307B
bioM?rieux S.A. designs, develops, manufactures and markets systems in the field of vitro diagnostics. The company provides diagnostic solutions which determine the source of disease and contamination. It also offers solutions for managing infectious diseases, cancers and cardiovascular diseases in clinical applications. The company provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for the agri-food, cosmetics and pharmaceutical industries. bioM?rieux S.A. is based in Marcy L Etoile, France.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $133.529B 24.94
Elevance Health (ELV) United States $96.108B 12.88
CVS Health (CVS) United States $84.839B 12.41
Cencora (COR) United States $55.604B 20.18
DiDi Global (DIDIY) China $20.317B 29.86
Natera (NTRA) United States $20.018B 0.00
Solventum (SOLV) United States $11.463B 10.69
ICON (ICLR) Ireland $11.251B 10.22
EUROFINS SCIENT (ERFSF) Luxembourg $11.063B 0.00
Revvity (RVTY) United States $11.032B 18.74
CochLear (CHEOY) Australia $10.876B 0.00
Avantor (AVTR) United States $10.289B 15.10
Doximity (DOCS) United States $9.934B 51.66
Viatris (VTRS) United States $9.024B 2.85
Medpace Holdings (MEDP) United States $8.956B 23.46
Sonic Healthcare (SKHHY) Australia $7.706B 0.00
HealthEquity (HQY) United States $7.311B 35.97
Charles River Laboratories (CRL) United States $5.209B 10.28
Amplifon S.p.A (AMFPF) Italy $4.285B 22.62
Bausch + Lomb (BLCO) Canada $4.262B 19.45
Alignment Healthcare (ALHC) United States $3.499B 0.00
Sotera Health (SHC) United States $2.975B 17.18
BrightSpring Health Services (BTSG) United States $2.905B 30.18
Organon (OGN) United States $2.868B 2.92
Surgery Partners (SGRY) United States $2.708B 31.21
GeneDx Holdings (WGS) United States $2.680B 318.23
Concentras Parent (CON) United States $2.613B 13.59
Progyny (PGNY) United States $1.837B 40.45
Ardent Health Partners (ARDT) United States $1.786B 0.00
Premier (PINC) United States $1.765B 11.30
GoodRx Holdings (GDRX) United States $1.720B 37.38
Agilon Health (AGL) United States $1.649B 0.00
PACS (PACS) United States $1.411B 0.00
Teladoc Health (TDOC) United States $1.197B 0.00
Pediatrix Medical (MD) United States $1.100B 9.22
Ryman Healthcare (RYHTY) New Zealand $1.035B 0.00
CareDx (CDNA) United States $0.977B 16.62
Establishment Labs Holdings (ESTA) $0.907B 0.00
Nutex Health (NUTX) United States $0.824B 16.14
AMN Healthcare Services Inc (AMN) United States $0.706B 5.59
Embecta (EMBC) United States $0.659B 4.52
Auna S.A (AUNA) Luxembourg $0.515B 13.65
QDM (QDMI) Hong Kong, SAR China $0.496B 0.00
SBC Medicals (SBC) United States $0.417B 0.00
Sonida Senior Living (SNDA) United States $0.405B 0.00
Enhabit (EHAB) United States $0.388B 36.57
InnovAge Holding (INNV) United States $0.372B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.290B 0.00
LifeMD (LFMD) United States $0.242B 0.00
DocGo (DCGO) United States $0.216B 8.83
Performant Healthcare (PHLT) United States $0.195B 0.00
Oncology Institute (TOI) United States $0.163B 0.00
Sera Prognostics (SERA) United States $0.128B 0.00
Beauty Health (SKIN) United States $0.106B 0.00
So-Young (SY) China $0.084B 0.00
Basel Medical Group (BMGL) Singapore $0.082B 0.00
OncoCyte (OCX) United States $0.081B 0.00
Biodesix (BDSX) United States $0.080B 0.00
Ascend Wellness Holdings (AAWH) United States $0.065B 0.00
IceCure Medical (ICCM) Israel $0.062B 0.00
NeueHealth (NEUE) United States $0.053B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.018B 0.00
ModivCare (MODV) United States $0.014B 4.93
Co-Diagnostics (CODX) United States $0.012B 0.00
SeaStar Medical Holding (ICU) United States $0.011B 0.00
KindlyMD (KDLY) United States $0.011B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
Aclarion (ACON) United States $0.005B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00